The long-range objective of this project is to characterize the behavioral and neurochemical effects of cocaine in nonhuman primates and to identify drugs that may have therapeutic value in treating stimulant abuse. Methods include schedule-controlled behavior as an index of CNS activity, intravenous self-administration of drugs as indicative of reinforcing efficacy or abuse liability, drugs as discriminative stimuli controlling behavior, and in vivo microdialysis techniques to allow for the measurement of direct neurochemical changes associated with drug effects on behavior. Efforts during the past year have focused on pharmacological manipulation of the serotonin system to assess changes in sensitivity to the CNS effects of cocaine. Administration of drugs that increase serotonergic activity reliably attenuated the behavioral-stimulant and reinforcing effects of cocaine. Moreover, drug interaction studies indicated that the serotonin system can provide inhibitory modul ation of psychomotor stimulants with selective dopaminergic actions. The latter results suggest that serotonergic modulation of cocaine and related abused stimulants may involve direct interactions between serotonin and dopamine. Cocaine and related dopamine transport blockers also caused pronounced increases in extracellular dopamine, and the drug potency and time course of action corresponded closely to drug-induced changes in schedule-controlled operant behavior. Collectively, these data indicate that the serotonin system may be an effective target for the treatment of cocaine abuse.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Primate Research Center Grants (P51)
Project #
5P51RR000165-37
Application #
6247320
Study Section
Project Start
1997-05-01
Project End
1998-04-30
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
37
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Emory University
Department
Type
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Beck, Goichi; Maehara, Shunsuke; Chang, Phat Ly et al. (2018) A Selective Phosphodiesterase 10A Inhibitor Reduces L-Dopa-Induced Dyskinesias in Parkinsonian Monkeys. Mov Disord 33:805-814
Georgieva, Maria; Sia, Jonathan Kevin; Bizzell, Erica et al. (2018) Mycobacterium tuberculosis GroEL2 Modulates Dendritic Cell Responses. Infect Immun 86:
Tedesco, Dana; Grakoui, Arash (2018) Environmental peer pressure: CD4+ T cell help in tolerance and transplantation. Liver Transpl 24:89-97
Mavigner, Maud; Habib, Jakob; Deleage, Claire et al. (2018) Simian Immunodeficiency Virus Persistence in Cellular and Anatomic Reservoirs in Antiretroviral Therapy-Suppressed Infant Rhesus Macaques. J Virol 92:
Walker, Lary C (2018) Prion-like mechanisms in Alzheimer disease. Handb Clin Neurol 153:303-319
Kamberov, Yana G; Guhan, Samantha M; DeMarchis, Alessandra et al. (2018) Comparative evidence for the independent evolution of hair and sweat gland traits in primates. J Hum Evol 125:99-105
Wakeford, Alison G P; Morin, Elyse L; Bramlett, Sara N et al. (2018) A review of nonhuman primate models of early life stress and adolescent drug abuse. Neurobiol Stress 9:188-198
Singh, Arun; Jenkins, Meagan A; Burke Jr, Kenneth J et al. (2018) Glutamatergic Tuning of Hyperactive Striatal Projection Neurons Controls the Motor Response to Dopamine Replacement in Parkinsonian Primates. Cell Rep 22:941-952
Maddox, S A; Kilaru, V; Shin, J et al. (2018) Estrogen-dependent association of HDAC4 with fear in female mice and women with PTSD. Mol Psychiatry 23:658-665
Li, Chun-Xia; Kempf, Doty J; Tong, Frank C et al. (2018) Longitudinal MRI Evaluation of Ischemic Stroke in the Basal Ganglia of a Rhesus Macaque (Macaca mulatta) with Seizures. Comp Med :

Showing the most recent 10 out of 912 publications